Speed to Biosimilars Market: How Digital Transformation Helps Win the Race
The Indian pharma sector is poised to take the lead in the biosimilars race and continue to live up to its reputation as the pharmacy of the world. However, the race is extremely competitive and fraught with challenges. Biosimilar development and manufacturing processes have different challenges than the established process for small molecules because of safety and efficacy risks associated with inherent biological variability and complex manufacturing. Higher regulatory scrutiny and R&D expenses need to be considered as well. To overcome these challenges, an enterprise-wide collaboration that leads to data-driven decisions and agility in R&D processes is critical.
In this webinar, we will present how PerkinElmer's Informatics solutions help accelerate the development of biosimilars from upstream to downstream processing and formulation by combining data management to acquire, explore, and analyse information from varied sources and make data-driven decisions as a team.
3 key learning points from webinar
Learn how R&D informatics solutions can help address key challenges in the biosimilars development process.
Understand how PerkinElmer Informatics' Electronic Lab Notebook (ELN) solutions can accelerate biosimilar development via the capture, analysis and sharing of experimental data.
Hear how advanced analytics can be leveraged to unify biological and analytical data resulting in faster data exploration, collaboration, and decision making.